These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate]. Jungers P; Liote F; Pelissier C; Viriot J; Laurent MC; Athea N; Dougados M; Lesavre P; Kuttenn F; Bach JF Ann Med Interne (Paris); 1986; 137(4):313-9. PubMed ID: 2946256 [TBL] [Abstract][Full Text] [Related]
3. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism. Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987 [TBL] [Abstract][Full Text] [Related]
4. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen. Garner PR; Poznanski N J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380 [TBL] [Abstract][Full Text] [Related]
5. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women. Frölich M; Lachinsky N; Moolenaar AJ Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326 [TBL] [Abstract][Full Text] [Related]
6. Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol. Jasonni VM; Bulletti C; Naldi S; Di Cosmo E; Cappuccini F; Flamigni C Fertil Steril; 1991 Apr; 55(4):742-5. PubMed ID: 1826278 [TBL] [Abstract][Full Text] [Related]
7. Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects. Marcondes JA; Wajchenberg BL; Abujamra AC; Luthold WW; Samojlik E; Kirschner MA Fertil Steril; 1990 Jan; 53(1):40-4. PubMed ID: 2136835 [TBL] [Abstract][Full Text] [Related]
8. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol. Jones DB; Ibraham I; Edwards CR Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264 [TBL] [Abstract][Full Text] [Related]
10. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism]. Pugeat M; Nicolas MH; Déchaud H; Elmidani M J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798 [TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Porcile A; Gallardo E Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074 [TBL] [Abstract][Full Text] [Related]
12. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate. Varenhorst E; Wallentin L; Carlström K Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762 [TBL] [Abstract][Full Text] [Related]
13. [Clinical results and hormonal aspects of the treatment of virilizing symptoms in women with cyproterone acetate (author's transl)]. Abrahamsson L; Hackl H; Sogn J; Stafsnes H Wien Klin Wochenschr; 1979 Feb; 91(4):126-30. PubMed ID: 154778 [TBL] [Abstract][Full Text] [Related]
14. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Bartsch W; Horst HJ; Becker H; Nehse G Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)]. Spona J; Huber J; Schmidt JB Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307 [TBL] [Abstract][Full Text] [Related]
16. Sex hormone binding globulin: binding capacity and studies on the binding of cyproterone acetate and other steroids. Frölich M; van Schie MG; Brand EC Clin Chim Acta; 1978 Jul; 87(2):239-44. PubMed ID: 566170 [TBL] [Abstract][Full Text] [Related]
17. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate. Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800 [TBL] [Abstract][Full Text] [Related]
18. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Sawers RS; Randall VA; Ebling FJ Br J Dermatol; 1986 Sep; 115(3):269-74. PubMed ID: 2944535 [TBL] [Abstract][Full Text] [Related]
19. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men. Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042 [TBL] [Abstract][Full Text] [Related]
20. Interaction of cyproterone acetate with sex hormone binding globulin of monkey plasma. Srivastava AK; Dey SB; Roy SK Exp Clin Endocrinol; 1983 Aug; 82(2):232-4. PubMed ID: 6226532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]